European Patent Attorney
Msc, PhD
Danielle joined Mathys & Squire in 2024 as an Associate within the life science and chemistry team. She is an experienced and commercially focused European Patent Attorney with extensive expertise in life sciences, biotechnologies, and pharmaceuticals. Her experience spans a diverse range of technology areas, including neurosciences, oncology, and rare diseases.
Leveraging her blend of in-house and private practice experience, Danielle is adept at conducting due diligence for merger and acquisition transactions as well as licensing agreements. She provides tailored advice that helps clients effectively navigate the intricate interplay between patents, regulatory requirements, and clinical considerations, ensuring alignment with their business objectives for optimal market protection.
Expertise
With a strong background in the pharmaceutical industry, Danielle has a comprehensive understanding of the entire spectrum of drug development—from early-stage R&D through to late-stage commercialisation. She delivers wide-ranging IP services, including patent drafting and prosecution, global patent portfolio management, development of IP strategy, European patent opposition, freedom to operate analysis, patentability assessment, market exclusivity evaluation, and competitor landscape analysis.
Additionally, Danielle provides flexible on-demand in-house counsel services, providing clients with direct access to her expertise as needed.
Academic
Danielle’s academic research explored the influence of stress hormones on brain development, cognition, and behaviour. Her multidisciplinary approach incorporated advanced techniques in molecular biology, electrophysiology, preclinical models, drug screening, and pharmacology, providing a strong scientific foundation for her current work in the life sciences sector.
Memberships & organisations
Sectors